The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment-Reference-Cited by-同舟云学术

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment

Published:2023-09-13 Issue:2 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Yin Shengxia¹,Wan Yawen²,Issa Rahma¹,Zhu Yijia³,Xu Xiaoming⁴,Liu Jiacheng¹,Mao Minxin⁴,Li Ming⁴,Tong Xin¹,Tian Chen⁵,Wang Jian¹,Huang Rui¹,Zhang Qun⁵,Wu Chao¹²,Chen Yuxin³,Li Jie¹

Affiliation:

1. Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of China

2. Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Xuzhou Medical University, Xuzhou, People’s Republic of China

3. Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of China

4. Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China

5. Department of Infectious Diseases, Affiliated Zhongda Hospital of Southeast University, Nanjing, People’s Republic of China

Funder

National Natural Science Fund

Nanjing Medical Science and Technique Development Foundation

Drum Tower Hospital, Medical School of Nanjing University

Natural Science Foundation of Shandong Province

Ji’nan Science and Technology Development

Jiangsu Commission of Health

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology